Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac muscle cell contraction refers to the process by which heart muscle (cardiomyocyte) contracts in response to an electrical stimulus. This involves excitation-contraction coupling, where an action potential triggers the opening of voltage-gated L-type calcium channels in the cell membrane, allowing calcium influx, which triggers further calcium release from the sarcoplasmic reticulum via ryanodine receptors. The resulting rise in cytosolic calcium binds to troponin-C, causing conformational changes that allow actin-myosin crossbridge cycling and muscle contraction. After contraction, calcium is resequestered into the sarcoplasmic reticulum or extruded from the cell to enable relaxation.
Modulating ion channel activity (e.g., L-type Ca²⁺ channels, Na⁺ channels, K⁺ channels); Modulating adrenergic signaling (through GPCRs); Altering intracellular calcium homeostasis; Influencing actin-myosin crossbridge cycling
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac muscle cell contraction.